The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Monday, February 08, 2021
AstraZeneca Pharmaceuticals
Matrix announced a collaboration with AstraZeneca to accelerate a clinical trial in the US for AZD7442, AstraZeneca's LAAB combination for the ...
read more
Friday, February 05, 2021
Johnson & Johnson announced Janssen Biotech has submitted an application to the FDA requesting EUA for its investigational single-dose Janssen COVID-...
read more
Friday, February 05, 2021
AstraZeneca Pharmaceuticals
Results demonstrated vaccine efficacy of 76% (CI: 59% to 86%) after a first dose, with protection maintained to the second dose.
read more
Thursday, February 04, 2021
Valneva has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies.
read more
Wednesday, February 03, 2021
Aeterna Zentaris has entered into an exclusive option agreement to evaluate a preclinical potential COVID-19 vaccine developed at the Julius-...
read more
Tuesday, February 02, 2021
Agenus has entered into a clinical collaboration with Nelum to evaluate the safety and efficacy of zalifrelimab in combination with NLM-001 and ...
read more
Tuesday, February 02, 2021
VBL Therapeutics announced the dosing of the first patient in study of oral immune-modulator molecule, VB-201 for the treatment of COVID-19.
read more
Monday, February 01, 2021
Clover Biopharmaceuticals and Dynavax Technologies announced the plan to initiate a global Phase 2/3 efficacy trial with the S-Trimer COVID-19 vaccine...
read more
J&J announced topline efficacy and safety data from the Phase 3 trial, demonstrating the investigational single-dose COVID-19 vaccine met all primary ...
read more
Novavax announced NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with a vaccine efficacy of 89.3%, in its Phase ...
read more
AstraZeneca Pharmaceuticals
AstraZeneca’s COVID-19 vaccine has been recommended for CMA in the EU for active immunization to prevent COVID-19 caused by SARS-CoV-2, in individuals...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Thursday, January 28, 2021
BioVaxys has commenced the clinical development program for BVX-0918A, its haptenized tumor antigen vaccine for ovarian cancer.
read more
Tuesday, January 26, 2021
Syntekabio and Hanmi Science have entered into a strategic collaboration to co-develop breakthrough COVID-19 treatments using drug repositioning ...
read more
Tuesday, January 26, 2021
Sirnaomics announced dose administration for the first patient in a Phase 2a clinical study of the company's lead drug candidate, STP705, for the ...
read more